Partner Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Partner Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers (NCT05588609) | Partner Therapeutics, Inc. | 2022-11-17 |
| Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation (NCT05366283) | Partner Therapeutics, Inc. | 2022-04-13 |
| Sargramostim Use in COVID-19 to Recover Patient Health (NCT04707664) | Partner Therapeutics, Inc. | 2021-04-27 |
| Study of Sargramostim in Patients With COVID-19 (NCT04411680) | Partner Therapeutics, Inc. | 2020-08-18 |
Track Partner Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.